'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Adeshwar Meditex Limited
ADESHWAR (BSE 543309) · ISIN INE0H8J01015 · Healthcare Research, Analytics & Technology · Est. 2007 · listed 2021 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹38.28 cr | ₹6 cr | ₹50.22 cr |
| 30 Sep 2025 standalone | ₹37.69 cr | ₹6.1 cr | ₹62.7 cr |
| 31 Mar 2025 standalone | ₹36.96 cr | ₹12.46 cr | ₹72.2 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 57.68% | — | — | 42.32% |
Latest filings
- Adeshwar Meditex Limited has submitted Scrutinizer''s report and Voting Results of the 19th Annual General Meeting of the company held on Wednesday, September 23, 2026 at 12:30 PM (IST) .... 23 September 2026 · BSE
- Adeshwar Meditex Limited has submitted Proceedings of the 19th Annual General Meeting of the Company held on Wednesday, 23rd September, 2026 at 12:30 PM (IST) at the registered office of the company. 23 September 2026 · BSE
- Adeshwar Meditex Limited has submitted Notice of 19th Annual General Meeting of the Company to be held on 23rd September, 2026 at the registered office of the Company at 12:30 PM (IST). 27 August 2026 · BSE
- Annual Report FY2025-26 (New) 27 August 2026 · BSE
- The agendas passed that the board meeting held today are stated in pdf signed outcome submitted 21 May 2026 · BSE
Other companies in Healthcare Research, Analytics & Technology
- GlobalSpace Technologies Limit
- Jeevan Scientific Technology L
- NOVELIX PHARMACEUTICALS LIMITE
- Vanta Bioscience Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.